ASSESSMENT OF KEY INDICATORS APPROVED BY THE REGIONAL PROGRAM ‘FIGHTING ONCOLOGICAL DISEASES’ IN A SPECIFIC SUBJECT OF THE RUSSIAN FEDERATION

DOI:10.22138/2500-0918-2024-21-1-72-85

O.V. Kuznetsova¹, I.V. Borzunov²,⁴, D.A. Demidov¹,
A.V. Stolin¹, L.A. Shabunina³

¹Ministry of Health of the Sverdlovsk Region, Yekaterinburg, Russian Federation;
²Federal State-Funded Educational Institution of Higher Education «Ural State University of Economics», Yekaterinburg, Russian Federation;
³State Autonomous Healthcare Institution «Sverdlovsk Regional Oncology Dispensary,» Yekaterinburg, Russian Federation;
⁴State Autonomous Healthcare Institution «Institute of Medical Cell Technologies», Yekaterinburg, Russian Federation

Abstract.
Malignant neoplasms rank second among the causes of death in the Russian Federation. The mortality rate from malignant neoplasms serves as an assessment of the population’s health. The research aim: was to evaluate the interim outcomes of the implementation of the regional program «Fighting Oncological Diseases in the Sverdlovsk Region». Materials and Methods. An analysis of the key indicator rates approved by the regional program «Fighting Oncological Diseases in the Sverdlovsk Region». Results. The dynamics of primary morbidity of malignant neoplasms, the proportion of patients in whom malignant neoplasms were detected at early stages, and the number of patients under outpatient care for five or more years, mortality and one-year mortality of patients with malignant neoplasms were studied. These indicators reflect the effectiveness of conducted activities, including early detection, treatment of malignant neoplasms, and the outpatient follow-up of oncology patients. Conclusions. The incidence and mortality rates of malignant neoplasms in the Sverdlovsk region characterize the performance of the regional oncology service. The benchmarks established in the regional program «Fighting Oncological Diseases» help identify trends and establish tasks for organizing effective assistance to patients with malignant neoplasms.

Keywords:
Malignant neoplasm, regional program, indicator, mortality, morbidity, analysis

There is no conflict of interest.
Contact details of the corresponding author:
Olga V. Kuznetsova
o.kuznetsova@egov66.ru
Received 25.12.2023
For citation:
Kuznetsova O.V., Borzunov I.V., Demidov D.A., Stolin A.V., Shabunina L.A. Assessment of key indicators approved by the regional program «Fighting oncological diseases» in a specific subject of the Russian Federation. [Online] Vestn. Ural. Med. Akad. Nauki. = Journal of Ural Medical Academic Science. 2024, Vol. 21, no. 1, pp. 72–85. DOI:10.22138/2500-0918-2024-21-1-72-85 (In Russ)

REFERENCES
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. DOI:10.3322/caac.21660.
2. World Health Organization (WHO). Global Health Estimates 2020: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2019. WHO; 2020. Accessed December 11, 2020. who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death.
3. Malignant neoplasms in Russia in 2022 (morbidity and mortality) / ed. by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Starinsky, A.O. Shakhzadova, Lisichnikova IV Moscow: Publishing house of P.A. Herzen MNIOI branch of FGBU «NMRC Radiology» of the Ministry of Health of Russia, 2023. 275 с. (InRuss.).
4. Shakhzadova AO, Starinskiy VV, Lisichnikova IV State of oncological care for the Russian population in 2022. Siberian Oncological Journal. 2023; 22(5): 5,13. DOI:10.21294/1814-4861-2023-22-5-5-5-13(InRuss.).
5. Kiku P.F., Alekseeva G.N., Izmailova O.A., Yudin S.V., Yudin S.S. «Model of organizing oncological care for the population of the region». Healthcare of the Russian Federation. 2017; 61(6): 284-291, (In Russ.).
6. Ulumbekova G.E., Al’vianskaya N.V., Petrachkov I.V. «Organization and financing of oncological care in the Russian Federation in 2018-2024». Bulletin of the VSHOUZ. 2022; Vol. 8, No. 1: 33-74, (In Russ.).
7. Agafonov Yu.A., Fedyaev D.V., Omelyanovsky V.V., Snegovoy A.V. Continuity of drug provision at outpatient and inpatient stages of therapy for oncology patients. Problems and solutions. Medical Technologies. 2021; (3): 37-44, (In Russ.).
8. Petkau V.V., Karimova A.A., Efremov S.A., Gruzdeva V.A. «Impact of antitumor drug treatment on target indicators of oncology service». Medical Herald. 2021; (45): 80-86, (In Russ.).
9. Tkacheva A.G., Nedochukova E.S., Podlubnaya L.V., Kravchenko D.A. «Role of the compulsory health insurance system in improving the efficiency of care in the Chelyabinsk region». National Healthcare. 2022; 3(2): 20-29, (In Russ.).

Authors
Olga V. Kuznetsova
Ministry of Health of the Sverdlovsk Region
Deputy Head of the Department for the Organization of Specialized Medical Care
o.kuznetsova@egov66.ru
Yekaterinburg, Russian Federation

Igor V. Borzunov
Ural State University of Economics
Doctor of Medical Sciences, Professor, Head of the Department of Social Sphere Economics
borzunov.i.v@yandex.ru
ORCID: 0000-0002-9827-8451
SPIN: 5502-4009
Author ID: 278458
Yekaterinburg, Russian Federation

Denis A. Demidov
Ministry of Health of the Sverdlovsk Region
Candidate of Medical Sciences, Associate Professor, Deputy Minister of Health of the Sverdlovsk Region
p18193@gmail.com
ORCID: 0009-0008-5139-5379
SPIN:5955-1660
Author ID: 541031
Yekaterinburg, Russian Federation

Alexey V. Stolin
Ministry of Health of the Sverdlovsk Region
Doctor of Medical Sciences, Head of the Department for the Organization of Specialized Medical Care
a.stolin@egov66.ru
Yekaterinburg, Russian Federation

Lyubov A. Shabunina
State Autonomous Healthcare Institution «Sverdlovsk Regional Oncology Dispensary»
Head of the Cancer Registry
org.uralonco@mail.ru
Yekaterinburg, Russian Federation